Resultados da pesquisa - Barbara Pro

Liquid biopsy for molecular profiling in cutaneous T-cell lymphoma: a pilot feasibility study Por Yoni Sacknovitz, Anna Sarah Erem, Joshua A. Kent, Maher Albitar, Tatyana Feldman, Barbara Pro, Seda S. Tolu, Alejandro A. Gru, Larisa Geskin

Obter o texto integral

Phase I study of novel SYK inhibitor TAK‐659 (mivavotinib) in combination with R‐CHOP for front‐line treatment of high‐risk diffuse large B‐cell lymphoma Por Reem Karmali, Frederique St‐Pierre, Shuo Ma, Kelly D. Foster, Jason Kaplan, Xinlei Mi, Barbara Pro, Jane N. Winter, Leo I. Gordon

Obter o texto integral

P1124: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL EXPANSION PHASE: OUTCOMES BY BASELINE HISTOLOGY Por Neha Mehta-Shah, Eric Jacobsen, Pier Luigi Zinzani, Jasmine Zain, Monica Mead, Carla Casulo, Giuseppi Gritti, Lauren Pinter-Brown, Koji Izutsu, Sheila Waters, Jonathan Brammer, Barbara Pro, Steven Horwitz

Obter o texto integral

Retrospective evaluation of R-EPOCH in the frontline treatment of adult patients with PTLD after solid organ transplant Por Brian Cuzzo, Maegan Ford, Saagar Jain, Hua-Jay Cherng, Evelyn Orlando, Patrick Gould, Amy Song, Benjamin May, Yuxuan Chen, Govind Bhagat, Andrew H. Lipsky, Barbara Pro, Jennifer E. Amengual

Obter o texto integral

Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin’s lymphoma: the updated M.... Por Paolo Anderlini, Rima Saliba, Sandra Acholonu, Sergio A. Giralt, Borje Andersson, Naoto T. Ueno, Chitra Hosing, Issa F. Khouri, Daniel Couriel, Marcos de Lima, Muzaffar H. Qazilbash, Barbara Pro, Jorge Romaguera, Luis Fayad, Frederick Hagemeister, Anas Younes, Mark F. Munsell, Richard E. Champlin

Obter o texto integral

Nivolumab in combination with R-CHOP for treatment-naïve diffuse large B-cell lymphoma: an evaluation of safety and efficacy Por Oluwatobi Odetola, Shuo Ma, Jane Winter, Barbara Pro, Ishan Roy, Ping Xie, Bin Zhang, Qing Chen, George P. Koulogeorgas, Xinlei Mi, Ruohui Chen, Yangruijue Ma, Xiaodan Tang, Robert Bayer, Robert Eisner, Valerie Nelson, Habib Shaikh, Dean Tsarwhas, Faisal Saghir, Parameswaran Venugopal, Leo I. Gordon, Reem Karmali

Obter o texto integral

Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy Por Reem Karmali, Geoffrey Shouse, Pallawi Torka, Tamara K. Moyo, Jason Romancik, Stefan K. Barta, Rahul Bhansali, Jonathon B. Cohen, Nirav N. Shah, Joanna Zurko, Vaishalee P. Kenkre, Brian Hess, Deborah M. Stephens, Lindsey Fitzgerald, Thomas Ollila, Bukky Tabiti, Ishan Roy, Shuo Ma, Jane Winter, Barbara Pro, Jonathan Moreira, Alexey V. Danilov, Kevin David, Leo I. Gordon, Narendranath Epperla

Obter o texto integral

Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up Por Eva Domingo-Domènech, Barbara Pro, Tim Illidge, Steven Horwitz, Lorenz Trumper, Swami Iyer, Ranjana Advani, Nancy L. Bartlett, Jacob Haaber Christensen, Won-Seog Kim, Tatyana Feldman, Ilseung Choi, Giuseppe Gritti, David Belada, Andrei Shustov, Arpad Illes, Pier Luigi Zinzani, Andreas Hüttmann, Marek Trneny, Steven Le Gouill, Deepa Jagadeesh, Jonathan W. Friedberg, Meredith Little, Cassie Dong, Michelle Fanale, Keenan Fenton, Kerry J. Savage

Obter o texto integral

Correction: Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ foll... Por Eva Domingo-Domènech, Barbara Pro, Tim Illidge, Steven Horwitz, Lorenz Trumper, Swami Iyer, Ranjana Advani, Nancy L. Bartlett, Jacob Haaber Christensen, Won-Seog Kim, Tatyana Feldman, Ilseung Choi, Giuseppe Gritti, David Belada, Andrei Shustov, Arpad Illes, Pier Luigi Zinzani, Andreas Hüttmann, Marek Trneny, Steven Le Gouill, Deepa Jagadeesh, Jonathan W. Friedberg, Meredith Little, Cassie Dong, Michelle Fanale, Keenan Fenton, Kerry J. Savage

Obter o texto integral

Posttransplant rituximab exposure and risk of PTLD in solid organ transplant recipients with EBV DNAemia Por Evelyn H. Orlando, Patrick Gould, Brian Cuzzo, Maegan Ford, Yuxuan Chen, Alexander Sanjurjo, Saagar Jain, Benjamin May, Demetra Tsapepas, Rebecca J. Leeman-Neill, Govind Bhagat, Geoffrey K. Dube, Heather Morris, Selim Arcasoy, Farhana Latif, Ersilia M. DeFilippis, Mercedes Martinez, Gene Y. Im, Meaghan M. Phipps, Marcus R. Pereira, Paul K. Sue, Manuela Orjuela-Grimm, Andrew H. Lipsky, Ahmed Sawas, Ran Reshef, Barbara Pro, Hua-Jay J. Cherng, Jennifer E. Amengual

Obter o texto integral

Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle... Por Julie M. Vose, Kai Fu, Lu Wang, Adnan Mansoor, Douglas Stewart, Hongxia Cheng, Lynette Smith, Ji Yuan, Hina Naushad Qureishi, Brian K. Link, Melissa H. Cessna, Paul M. Barr, Brad S. Kahl, Matthew S. Mckinney, Nadia Khan, Ranjana H. Advani, Peter Martin, Andre H. Goy, Tycel J. Phillips, Amitkumar Mehta, Manali Kamdar, Michael Crump, Barbara Pro, Christopher R. Flowers, Caron A. Jacobson, Sonali M. Smith, Deborah M. Stephens, Veronika Bachanova, Zhaohui Jin, Shishou Wu, Francisco Hernandez-Ilizaliturri, Pallawi Torka, Andrea Anampa-Guzmán, Farshid Kashef, Xing Li, Sunandini Sharma, Timothy C. Greiner, James O. Armitage, Matthew Lunning, Dennis D. Weisenburger, Robert G. Bociek, Javeed Iqbal, Guohua Yu, Chengfeng Bi, the North American Mantle Cell Lymphoma Consortium

Obter o texto integral